Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Fresenius plans to sell rehabilitation care clinics - FAZ
09:55am, Friday, 08'th Dec 2023
Fresenius has hired UBS to manage the sale of its rehabilitation care clinic business as the German healthcare group focuses on core activities, Frankfurter Allgemeine Zeitung reported on Friday, citi
Fresenius Medical Care says data on 500,000 people stolen in U.S.
09:52am, Wednesday, 06'th Dec 2023
Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a U.S. subsidiary's database.
Fresenius Medical (FMS) Ups '23 Outlook After Legal Settlement
08:16am, Thursday, 23'rd Nov 2023
Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
09:46am, Wednesday, 22'nd Nov 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
11:13am, Friday, 10'th Nov 2023
That's the message from many corporate executives who have lately been peppered with questions about how Wegovy, Ozempic and other drugs widely used for weight loss may impact their bottom line.
Fresenius Medical (FMS) Q3 Earnings Miss, Operating Margin Up
11:18am, Friday, 03'rd Nov 2023
Fresenius Medical's (FMS) third-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call Transcript
04:51pm, Thursday, 02'nd Nov 2023
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call Transcript
Top Medical Stocks to Buy Amid Recent Market Volatility
07:33pm, Monday, 23'rd Oct 2023
Several Zacks Medical sector stocks were recently added to the Zacks Rank #1 (Strong Buy) list over the last week and should be viable options for investors during economic uncertainty as healthcare i
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?
11:18am, Friday, 20'th Oct 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Here's Why You Should Retain Fresenius Medical (FMS) for Now
09:01am, Monday, 16'th Oct 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical: use of drugs like Ozempic has neutral effect on dialysis patient numbers
12:14pm, Thursday, 12'th Oct 2023
Germany's Fresenius Medical Care , said that use of Ozempic, and other diabetes and weight-loss drugs of the same class, would have an overall neutral effect on how many patients will require the comp
What other industries could weight loss drugs disrupt?
07:10pm, Wednesday, 11'th Oct 2023
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
Why Dialysis Stocks Plunged Today
12:51pm, Wednesday, 11'th Oct 2023
Novo Nordisk shares rallied after it announced it will stop its FLOW trial nearly a year earlier than expected after positive feedback on interim data for semaglutide's ability to treat kidney disease
Why Shares of Fresenius Medical Care Were Dropping on Wednesday
12:18pm, Wednesday, 11'th Oct 2023
Novo Nordisk ended a phase 3 trial early for Ozempic for preventing kidney disease because the trial was so successful. Fresenius and other dialysis-connected companies saw their shares fall on Wednes
Ozempic Is Moving a Bunch of Stocks Wednesday Morning
09:37am, Wednesday, 11'th Oct 2023
Markets were poised to move higher again on Wednesday morning. Shares of Novo Nordisk climbed on good news from a study of its drug Ozempic on kidney patients.
